Fecal microbes therapy to help prevent graft-versus-host disease
Part of Immune system & allergy clinical trials.
This trial studies a treatment made from donor gut microbes to help prevent a common complication after a transplant called acute graft-versus-host disease (aGVHD). It may help by improving the balance and variety of gut bacteria during recovery after haploidentical transplant.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You had a haploidentical transplant (often called haplo-HSCT)
- Your stool test shows Bacteroidetes bacteria are above 0.1%
- Your stool test shows your gut bacteria variety is high (inverse Simpson diversity at least 2)
- You are between 10 and 60 years old (not older than 60, not younger than 10)
- You do not have a significant gastrointestinal illness right now
- You did not take probiotics or prebiotics before starting the trial
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether a fecal transplant (FMT) can help treat gut graft-versus-host disease (gut GVHD), a condition where donated immune cells attack the intestines. If you have gut GVHD and meet age requirements, you may be eligible to receive this treatment in the trial.
This trial tests whether transferring healthy gut bacteria from a donor to patients can help heal severe intestinal damage that occurs after bone marrow or stem cell transplants. The goal is to reduce pain, inflammation, and other complications from this serious side effect.
This study tests whether a fecal transplant (transferring healthy donor bacteria into your gut) can help your immune system recover after a stem cell transplant. It may reduce the risk of infections while your immunity is still low.
This study tests whether restoring healthy gut bacteria using a fecal microbiota transplant can improve steroid-refractory gut graft-versus-host disease (aGvHD) after stem cell transplant. If your gut symptoms are your first episode and your stool bacteria diversity is low, this trial may be an option worth screening for.
This trial tests whether giving a fecal transplant (a procedure that transfers healthy bacteria from a donor's stool into your gut) can help children whose gut graft-versus-host disease (a common complication after a stem cell transplant) is not improving with standard steroid treatment.
This study tests whether a fecal microbiota transplant (a procedure that puts healthy donor bacteria into your gut) combined with a dietary fiber supplement can help treat gut graft-versus-host disease, a common complication after a stem cell transplant. It may help reduce diarrhea and other gut symptoms.
Hear when a new Graft Versus Host Disease, Acute trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.